Consideration of confounders, accuracy of diagnosis, and disease severity in assessing the risk of inflammatory bowel disease in patients with psoriasis and psoriatic arthritis/ankylosing spondylitis beginning interleukin-7 inhibitor treatment: comment on the article by Penso et al

Arthritis Rheumatol. 2022 Mar;74(3):546-547. doi: 10.1002/art.41960. Epub 2022 Feb 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arthritis, Psoriatic* / complications
  • Arthritis, Psoriatic* / diagnosis
  • Arthritis, Psoriatic* / drug therapy
  • Humans
  • Inflammatory Bowel Diseases* / complications
  • Inflammatory Bowel Diseases* / drug therapy
  • Interleukin-7
  • Psoriasis* / complications
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Spondylitis, Ankylosing* / diagnosis

Substances

  • Interleukin-7